Replies to post #5864 on Ariad Pharmaceuticals Inc fka ARIA

[iandy]

I am not as versed in the technical aspects of the OS evaluation as I would like.
The fact is there was enough of a response in the progression aspect of the trial for Harvey to make a public statement saying it was a success. Harvey also said some patients had a much greater response than the mean.
Do the results that have been disclosed infer that our odds of the OS being significant enough for approval are much better than even money?

[DewDiligence]

Rida's OS HR of 0.92 is not quite as good as the 0.85 figure previously posted as the threshold for what I would consider a strong outcome (#msg-60136247). However, the 0.92 figure is not final, so it could improve when all of the survival data are in.